Roble Belko & Company’s Molina Healthcare MOH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7K Hold
30
﹤0.01% 334
2026
Q1
$4K Hold
30
﹤0.01% 358
2025
Q4
$5K Hold
30
﹤0.01% 346
2025
Q3
$6K Hold
30
﹤0.01% 305
2025
Q2
$9K Hold
30
﹤0.01% 284
2025
Q1
$10K Hold
30
﹤0.01% 258
2024
Q4
$9K Hold
30
﹤0.01% 251
2024
Q3
$10K Hold
30
﹤0.01% 234
2024
Q2
$9K Hold
30
﹤0.01% 241
2024
Q1
$12K Hold
30
﹤0.01% 237
2023
Q4
$11K Hold
30
﹤0.01% 230
2023
Q3
$10K Buy
+30
New +$9.44K ﹤0.01% 214

Other funds holding MOH

Roble Belko & Company's MOH Position: Q2 2026 in Review

Roble Belko & Company held its Molina Healthcare (MOH) position steady in Q2 2026 at 30 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #334.

Roble Belko & Company first reported a position in MOH in Q3 2023 and has held it in 12 quarters since. The position peaked at $12K in Q1 2024. 602 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

  • Roble Belko & Company held 30 shares of Molina Healthcare worth $7K as of Q2 2026.
  • Roble Belko & Company left its Molina Healthcare share count unchanged in Q2 2026.
  • Molina Healthcare made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #334 holding.
  • Roble Belko & Company first reported a position in Molina Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Roble Belko & Company's Molina Healthcare position peaked at $12K in Q1 2024.
  • 602 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.